114 related articles for article (PubMed ID: 16900951)
1. Comparison of folic acid uptake characteristics by human placental choriocarcinoma cells at acidic and physiological pH.
Keating E; Lemos C; Azevedo I; Martel F
Can J Physiol Pharmacol; 2006 Feb; 84(2):247-55. PubMed ID: 16900951
[TBL] [Abstract][Full Text] [Related]
2. Characterization of uptake of folates by rat and human blood-brain barrier endothelial cells.
Araújo JR; Gonçalves P; Martel F
Biofactors; 2010; 36(3):201-9. PubMed ID: 20232349
[TBL] [Abstract][Full Text] [Related]
3. Uptake mechanism of valproic acid in human placental choriocarcinoma cell line (BeWo).
Ushigome F; Takanaga H; Matsuo H; Tsukimori K; Nakano H; Ohtani H; Sawada Y
Eur J Pharmacol; 2001 Apr; 417(3):169-76. PubMed ID: 11334847
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a folate transporter in HeLa cells with a low pH optimum and high affinity for pemetrexed distinct from the reduced folate carrier.
Wang Y; Zhao R; Goldman ID
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6256-64. PubMed ID: 15448015
[TBL] [Abstract][Full Text] [Related]
5. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.
Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G
Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196
[TBL] [Abstract][Full Text] [Related]
6. Differential usage of the transport systems for folic acid and methotrexate in normal human T-lymphocytes and leukemic cells.
Biswal BK; Verma RS
J Biochem; 2009 Nov; 146(5):693-703. PubMed ID: 19692428
[TBL] [Abstract][Full Text] [Related]
7. Characterization of folate transport mediated by a low pH route in mouse L1210 leukemia cells with defective reduced folate carrier function.
Sierra EE; Goldman ID
Biochem Pharmacol; 1998 May; 55(9):1505-12. PubMed ID: 10076544
[TBL] [Abstract][Full Text] [Related]
8. Contrasting effects of oncogene expression on two carrier-mediated systems internalizing folate compounds in Fisher rat 3T3 cells.
Kühnel JM; Chiao JH; Sirotnak FM
J Cell Physiol; 2000 Sep; 184(3):364-72. PubMed ID: 10911368
[TBL] [Abstract][Full Text] [Related]
9. Carrier-mediated transport of folic acid in BeWo cell monolayers as a model of the human trophoblast.
Takahashi T; Utoguchi N; Takara A; Yamamoto N; Nakanishi T; Tanaka K; Audus KL; Watanabe Y
Placenta; 2001 Nov; 22(10):863-9. PubMed ID: 11718574
[TBL] [Abstract][Full Text] [Related]
10. The mechanism of carrier-mediated transport of folates in BeWo cells: the involvement of heme carrier protein 1 in placental folate transport.
Yasuda S; Hasui S; Kobayashi M; Itagaki S; Hirano T; Iseki K
Biosci Biotechnol Biochem; 2008 Feb; 72(2):329-34. PubMed ID: 18256483
[TBL] [Abstract][Full Text] [Related]
11. Antifolate resistance in a HeLa cell line associated with impaired transport independent of the reduced folate carrier.
Zhao R; Chattopadhyay S; Hanscom M; Goldman ID
Clin Cancer Res; 2004 Dec; 10(24):8735-42. PubMed ID: 15623659
[TBL] [Abstract][Full Text] [Related]
12. Riboflavin uptake in human trophoblast-derived BeWo cell monolayers: cellular translocation and regulatory mechanisms.
Huang SN; Swaan PW
J Pharmacol Exp Ther; 2001 Jul; 298(1):264-71. PubMed ID: 11408551
[TBL] [Abstract][Full Text] [Related]
13. Multiple membrane transport systems for the uptake of folate-based thymidylate synthase inhibitors.
Jansen G; Schornagel JH; Westerhof GR; Rijksen G; Newell DR; Jackman AL
Cancer Res; 1990 Dec; 50(23):7544-8. PubMed ID: 2253202
[TBL] [Abstract][Full Text] [Related]
14. Characterization of glucose transport and glucose transporters in the human choriocarcinoma cell line, BeWo.
Shah SW; Zhao H; Low SY; Mcardle HJ; Hundal HS
Placenta; 1999 Nov; 20(8):651-9. PubMed ID: 10527819
[TBL] [Abstract][Full Text] [Related]
15. Apical uptake of choline and cationic drugs in epithelial cell lines derived from human placenta.
Müller J; Born I; Neubert RH; Brandsch M
Placenta; 2005; 26(2-3):183-9. PubMed ID: 15708119
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of human proton-coupled folate transporter/heme carrier protein 1 heterologously expressed in mammalian cells as a folate transporter.
Nakai Y; Inoue K; Abe N; Hatakeyama M; Ohta KY; Otagiri M; Hayashi Y; Yuasa H
J Pharmacol Exp Ther; 2007 Aug; 322(2):469-76. PubMed ID: 17475902
[TBL] [Abstract][Full Text] [Related]
17. The BeWo choriocarcinoma cell line as a model of iodide transport by placenta.
Manley SW; Li H; Mortimer RH
Placenta; 2005 May; 26(5):380-6. PubMed ID: 15850642
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate influx via folate transporters into alveolar epithelial cell line A549.
Kawami M; Miyamoto M; Yumoto R; Takano M
Drug Metab Pharmacokinet; 2015 Aug; 30(4):276-81. PubMed ID: 26190800
[TBL] [Abstract][Full Text] [Related]
19. Transport of methotrexate into PC-3 human prostate cancer cells.
Horne DW; Reed KA
Arch Biochem Biophys; 2001 Oct; 394(1):39-44. PubMed ID: 11566025
[TBL] [Abstract][Full Text] [Related]
20. Carrier-mediated hepatobiliary transport of a novel antifolate, N-[4-[(2,4-dianninopteridine-6-yl)methyl]-3,4-dihydro-2H-1,4-benzothiazin-7-yl]carbonyl-L-homoglutamic acid, in rats.
Han YH; Kato Y; Watanabe Y; Terao K; Asoh Y; Sugiyama Y
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):394-400. PubMed ID: 11259322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
